The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of generics on drug volume and expenditures in oncology: A 2005-14 MIDAS analysis.
 
Victoria Divino
Employment - IMS Health
Research Funding - IMS Health
 
Katharine Coyle
Employment - IMS Health
Research Funding - IMS Health
 
Satyin Kaura
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Michael Kleinrock
Employment - IMS Health
Research Funding - IMS Health
 
Rolin L. Wade
Employment - IMS Health
Stock and Other Ownership Interests - Abbvie; Acceleron Pharma; Amgen; Anthem; Baxalta; Baxter; Bristol-Myers Squibb; Celgene; Cerner; Gilead Sciences; Johnson & Johnson; Medicus Economics; Medtronic; Novartis; Procter & Gamble
Research Funding - Abbvie (Inst); Amgen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); LEO Pharma (Inst); Medison (Inst); Merck (Inst); Novartis (Inst); Purdue Pharma (Inst); Sanofi (Inst); Takeda (Inst); UCB (Inst); Walgreens (Inst)
 
Mitch DeKoven
Employment - IMS Health
Research Funding - IMS Health